These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10048654)

  • 21. Contact sensitization in children with atopic dermatitis.
    Ozceker D; Haslak F; Dilek F; Sipahi S; Yucel E; Guler N; Tamay Z
    Allergol Immunopathol (Madr); 2019; 47(1):47-51. PubMed ID: 30193890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder.
    Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
    Vaccine; 2015 May; 33(21):2511-6. PubMed ID: 25562790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.
    Geier DA; Kern JK; King PG; Sykes LK; Geier MR
    Biol Trace Elem Res; 2015 Feb; 163(1-2):28-38. PubMed ID: 25382662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic and toxic reactions of soft contact lens wearers.
    Mondino BJ; Salamon SM; Zaidman GW
    Surv Ophthalmol; 1982; 26(6):337-44. PubMed ID: 6810487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
    Dórea JG
    Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
    Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autism and vaccination-the current evidence.
    Miller L; Reynolds J
    J Spec Pediatr Nurs; 2009 Jul; 14(3):166-72. PubMed ID: 19614825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimum eliciting patch test concentration of thimerosal.
    Lisi P; Perno P; Ottaviani M; Morelli P
    Contact Dermatitis; 1991 Jan; 24(1):22-6. PubMed ID: 2044366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thimerosal: current sources of contact in Brazil.
    Rocha VB; Scherrer MA
    An Bras Dermatol; 2014; 89(2):376-8. PubMed ID: 24770530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contact sensitivity to preservatives in Turkey.
    Boyvat A; Akyol A; Gürgey E
    Contact Dermatitis; 2005 Jun; 52(6):329-32. PubMed ID: 15932584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically Relevant Reactions to Thimerosal (the "Nonallergen") Exist!
    Aschenbeck KA; Warshaw EM
    Dermatitis; 2018; 29(1):44-45. PubMed ID: 28538009
    [No Abstract]   [Full Text] [Related]  

  • 33. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG; Marques RC; Brandão KG
    Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What's new in contact dermatitis: allergy to topical steroids in Israeli patients with contact dermatitis.
    Ingber A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):867. PubMed ID: 12455163
    [No Abstract]   [Full Text] [Related]  

  • 35. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.
    Mrozek-Budzyn D; Majewska R; Kieltyka A; Augustyniak M
    Neurotoxicol Teratol; 2012; 34(6):592-7. PubMed ID: 23069197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET; Fiore AE; Strine TW; Barker LE
    JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose Thimerosal in pediatric vaccines: Adverse effects in perspective.
    Dórea JG
    Environ Res; 2017 Jan; 152():280-293. PubMed ID: 27816865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional study of the relationship between infant Thimerosal-containing hepatitis B vaccine exposure and attention-deficit/hyperactivity disorder.
    Geier DA; Kern JK; Homme KG; Geier MR
    J Trace Elem Med Biol; 2018 Mar; 46():1-9. PubMed ID: 29413097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
    Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].
    García-Fernández L; Hernández AV; Suárez Moreno V; Fiestas F
    Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):268-74. PubMed ID: 23949514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.